The AIM with Immunotherapy Initiative – Home › Forums › Intralesional immunotherapy › Side-effect management › Ocular herpes › Reply To: Ocular herpes
January 3, 2018 at 9:34 pm #4588
Expert NurseKrista Rubin
Curious to hear how others would handle:
Would your practice consider TVEC for a patient with a HISTORY OF recurrent herpetic infections (including ocular) that required daily suppression?